What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid
GLP-1s, a class of drugs used to treat type 2 diabetes, obesity, cardiovascular disease, and other conditions, have exploded in popularity in recent years due to their demonstrated effectiveness, but are often not covered by insurance, particularly for the treatment of obesity. According to KFF polling, about half (56%) of GL...
The article discusses two initiatives aimed at addressing the growing problem of obesity and high prescription drug costs among Medicare beneficiaries. The Medicare Obesity Treatment demonstration is a new demonstration by the Centers for Medicare & Medicaid Services (CMS) that will test the effectiveness of expanding access to prescription drugs used to treat obesity. The Bipartisan Safer Medicare Act is a separate initiative that aims to lower prescription drug prices for Medicare beneficiarie...